Basic information Description References Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Neuronal Signaling >  5-HT Receptor agonists >  Rizatriptan benzoate

Rizatriptan benzoate

Basic information Description References Safety Supplier Related

Rizatriptan benzoate Basic information

Product Name:
Rizatriptan benzoate
Synonyms:
  • RIZATRIPTAN BENZOATE
  • N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE, BENZOATE
  • n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethylamine benzoate
  • Rizatrimptan Benzoate
  • Rizatrimptan
  • Rizatriptan monobenzoate
  • N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-
  • Acid Bixente triptans
CAS:
145202-66-0
MF:
C22H25N5O2
MW:
391.48
EINECS:
604-465-6
Product Categories:
  • MK-462, Maxalt
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Neurochemicals
  • Pharmaceuticals
  • API
  • Antimigraine
  • Heterocyclic Compounds
  • Rizatriptan
  • Amines
Mol File:
145202-66-0.mol
More
Less

Rizatriptan benzoate Chemical Properties

Melting point:
178-180°C
storage temp. 
2-8°C
solubility 
H2O: ≥5mg/mL
form 
powder
color 
white to beige
Merck 
14,8241
InChIKey
JPRXYLQNJJVCMZ-UHFFFAOYSA-N
CAS DataBase Reference
145202-66-0(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
61
WGK Germany 
3
HS Code 
2933995500
More
Less

Rizatriptan benzoate Usage And Synthesis

Description

Known as a 5-hydroxytryptamine agonist, Rizatriptan Benzoate is the benzoate salt form of rizatriptan with anti-migraine activity, which can be used to treat the migraine headaches. It is FDA-approved to use in the treatment of acute migraine attacks with or without aura, especially taken at the first sign of a migraine headache. However, it cannot prevent future migraine attacks and it is ineffective to prevent other types of headache.
The pain of migraine headaches is believed to be induced by dilated blood vessels inside the head. Rizatriptan Benzoate relieves the pain by inducing vasoconstriction, which functions as an agonist at serotonin 5-HT1B and 5-HT1D receptors. The selective receptor binding is effective to constrict cranial vessels and inhibit the transmission of nociception, thus providing relief of migraine headaches.

References

https://en.wikipedia.org/wiki/Rizatriptan
https://pubchem.ncbi.nlm.nih.gov/compound/77997#section=Top
http://bodyandhealth.canada.com/drug/getdrug/co-rizatriptan-odt

Description

Rizatriptan was launched for the first time as Maxalt in Mexico for the acute treatment of migraine headaches with or without aura in adults. It is the third in a new generation of triptan migraine drugs to challenge the firstgeneration product Sumatriptan from Glaxo Wellcome, after Zolmitriptan (Zeneca) and Naratriptan (Glaxo Wellcome).
It can be synthetically obtained by two related routes having respectively 3 and 4 steps, both starting from 1 -(4-aminobenzyl)-l,2,4-triazole. Rizatriptan is a full 5-HT1D/1B receptor agonist retaining a significant affinity at 5-HT1A sites (pIC50 = 6.4), with a low affinity for nond-HT sites. It shows craniovascufar selectivity for human isolated middle meningeal over coronary arteries ; its effect on coronary artery constriction is significantly less than that for Sumatriptan. Rizatriptan inhibits the release of neuropeptides that cause swelling of cranial blood vessels. Rizatriptan has a good oral bioavailability (64% and 47% in rats and dogs respectively). and a rapid onset of action : the headache relief in human occurs within 30 to 45 minutes of taking 20 mg. It also relieved nausea and hypersensitivity to noise (phonophobia) and light (photophobia) that are often symptoms accompanying a migraine attack. Among at least 6 metabolites identified in humans after a single oral dose (60 mg), the major urinary metabolite was the corresponding indole-3-acetic acid. Maxalt is available as a novel oral formulation of rapidly dissolving tablets or wafers that does not require liquid for ingestion.

Chemical Properties

Off-White Solid

Originator

Merck & Co (US)

Uses

Rizatriptan Benzoate is a selective serotonin 5-HTID receptor agonist and used to treat migraine (1,2,3). It is structurally derived from tryptamine.

Uses

Rizatriptan Benzoate(Maxalt) is a 5-HT1 agonist triptan drug for the treatment of migraine headaches. It is believed to work by narrowing the blood vessels around the brain. Rizatriptan also reduces the substances in the body, which can also reduce headac

Uses

A selective serotonin 5-HTID receptor agonist. Structurally derived from tryptamine

Definition

ChEBI: Rizatriptan benzoate is a member of tryptamines.

brand name

Maxalt (Merck).

General Description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Biochem/physiol Actions

Rizatriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine.

Rizatriptan benzoate Supplier

Kunming New Biopharmaceutical Co., Ltd. Gold
Tel
0871-63857628
Email
1134540013@qq.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com